De novo missense variants in HCN1 were first reported in 2014 as a cause of early infantile epileptic encephalopathy (EIEE)/developmental and epileptic encephalopathy (DEE), characterized by infantile onset, frequent drug resistance, and fever/heat sensitivity (19). Here, HCN1 is linked to developmental and epileptic encephalopathy.